123 related articles for article (PubMed ID: 4089011)
1. Might adriamycinol contribute to adriamycin-induced cardiotoxicity?
Del Tacca M; Danesi R; Ducci M; Bernardini C; Romanini A
Pharmacol Res Commun; 1985 Nov; 17(11):1073-84. PubMed ID: 4089011
[TBL] [Abstract][Full Text] [Related]
2. The influence of amrinone on cardiac toxicity induced by adriamycin in rats.
Bernardini C; Del Tacca M; Danesi R; Della Torre P
Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):243-53. PubMed ID: 3789887
[TBL] [Abstract][Full Text] [Related]
3. General and cardiac toxicity of adriamycinol in rats.
Danesi R; Del Tacca M; Della Torre P; Bernardini C
Anticancer Res; 1986; 6(5):967-72. PubMed ID: 3800337
[TBL] [Abstract][Full Text] [Related]
4. Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.
Agen C; Bernardini N; Danesi R; Della Torre P; Costa M; Del Tacca M
Cancer Chemother Pharmacol; 1992; 30(2):95-9. PubMed ID: 1600601
[TBL] [Abstract][Full Text] [Related]
5. Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4'-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues.
Cummings J; Willmott N; More I; Kerr DJ; Morrison JG; Kaye SB
Biochem Pharmacol; 1987 May; 36(9):1521-6. PubMed ID: 3579988
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxic effects of adriamycin and mitochondrial oxidation in rat cardiac tissue.
Montali U; Del Tacca M; Bernardini C; Segnini D; Solaini G
Drugs Exp Clin Res; 1985; 11(3):219-22. PubMed ID: 3836126
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of selenium, WR-2721, and their combination in the prevention of adriamycin-induced cardiotoxicity in rats.
Dobrić S; Dragojević-Simić V; Bokonjić D; Milovanović S; Marincić D; Jović P
J Environ Pathol Toxicol Oncol; 1998; 17(3-4):291-9. PubMed ID: 9726805
[TBL] [Abstract][Full Text] [Related]
8. Comparative metabolism and elimination of adriamycin and 4'-epiadriamycin in the rat.
Sweatman TW; Israel M
Cancer Chemother Pharmacol; 1987; 19(3):201-6. PubMed ID: 3472675
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity.
Deepa PR; Varalakshmi P
Chem Biol Interact; 2003 Oct; 146(2):201-10. PubMed ID: 14597133
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the S alpha T segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the rat.
Danesi R; Del Tacca M; Soldani G
J Pharmacol Methods; 1986 Nov; 16(3):251-9. PubMed ID: 3784571
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of glutathione administration on adriamycin-induced acute cardiac toxicity in rats.
Mohamed HE; El-Swefy SE; Hagar HH
Pharmacol Res; 2000 Aug; 42(2):115-21. PubMed ID: 10887039
[TBL] [Abstract][Full Text] [Related]
12. Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D.
Terasaki T; Iga T; Sugiyama Y; Sawada Y; Hanano M
J Pharmacobiodyn; 1984 May; 7(5):269-77. PubMed ID: 6470925
[TBL] [Abstract][Full Text] [Related]
13. Cytofluorescence localization and disposition of doxorubicin and doxorubicinol in rat cardiac tissue.
Danesi R; Paparelli A; Bernardini N; Del Tacca M
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1123-31. PubMed ID: 3416897
[TBL] [Abstract][Full Text] [Related]
14. Protective role of granulocyte colony-stimulating factor against adriamycin induced cardiac, renal and hepatic toxicities.
Hou XW; Jiang Y; Wang LF; Xu HY; Lin HM; He XY; He JJ; Zhang S
Toxicol Lett; 2009 May; 187(1):40-4. PubMed ID: 19429242
[TBL] [Abstract][Full Text] [Related]
15. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).
Cummings J; Merry S; Willmott N
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):451-60. PubMed ID: 3460809
[TBL] [Abstract][Full Text] [Related]
16. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the cardioprotective effects of docetaxel pre-administration against adriamycin-induced cardiotoxicity.
Tomonari M; To H; Nishida M; Mishima T; Sasaki H; Kurose H
J Pharmacol Sci; 2011; 115(3):336-45. PubMed ID: 21358119
[TBL] [Abstract][Full Text] [Related]
18. [Cardiotoxicity study of ME2303 with the interval intravenous injections to rats].
Aoyama M; Kato S; Kodama I; Toyama J; Watanabe T; Kawaoto H; Asaoka H; Kurebe M
Jpn J Antibiot; 1990 Jul; 43(7):1230-7. PubMed ID: 2232153
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
Yilmaz S; Atessahin A; Sahna E; Karahan I; Ozer S
Toxicology; 2006 Feb; 218(2-3):164-71. PubMed ID: 16325981
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Piper longum L. on oxidative stress induced injury and cellular abnormality in adriamycin induced cardiotoxicity in rats.
Wakade AS; Shah AS; Kulkarni MP; Juvekar AR
Indian J Exp Biol; 2008 Jul; 46(7):528-33. PubMed ID: 18807757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
